Cryopreservation Bags and Freezing Bags Market Size & Growth

Cryopreservation Bags and Freezing Bags market size was valued at USD 921 million in 2024 and is projected to reach USD 1,745.9 million by 2032.

By End User (Biobanks, Hospitals & Transfusion Centers, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies); By Material (EVA (Ethylene Vinyl Acetate), PVC (Polyvinyl Chloride), Polyolefin, Others); By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); By Type of Analyte Stored (Blood, Biologics, Tissues)

SKU: CR5105Report Pages: 250Category: Medical DevicesReport Format: PDF, ExcelLast Updated: Jun 18Author: Rajdeep Kumar DebReviewed by: Deepti AgrawalPreferred on

Market Report Metrics

Revenue, 2024 -
USD 921 million
Forecast Year -
2032
CAGR (2024–2032)
8.13%
Report Coverage
Global
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Cryopreservation Bags and Freezing Bags Market Size 2024  USD 921 Million
Cryopreservation Bags and Freezing Bags Market, CAGR  8.13%
Cryopreservation Bags and Freezing Bags Market Size 2032  USD 1,745.9 Million

Market Overview

The Cryopreservation Bags and Freezing Bags market is projected to grow from USD 921 million in 2024 to USD 1,745.9 million by 2032, reflecting a compound annual growth rate (CAGR) of 8.13%.

The Cryopreservation Bags and Freezing Bags market is driven by the increasing demand for biobanking and regenerative medicine, as these technologies require reliable preservation solutions. Advances in biotechnology and the growing focus on personalized medicine are boosting market growth, as they necessitate the storage of cells, tissues, and biological samples. Additionally, the rise in chronic diseases and the expansion of stem cell research are key trends propelling the market forward. Innovations in bag materials and designs, enhancing durability and reducing contamination risks, further support the market's expansion and adoption across various medical and research applications.

The Cryopreservation Bags and Freezing Bags market is geographically diverse, with significant growth observed in North America, Europe, and Asia-Pacific. North America leads due to advanced biobanking infrastructure and strong research activities, while Europe follows closely with robust healthcare systems and regulatory support. The Asia-Pacific region is rapidly expanding, driven by increasing investments in biotechnology and healthcare infrastructure. Key players such as American Durafilm, Biomed Device, CellBios, Charter Medical, Instant Systems, Macopharma, OriGen Biomedical, and Sartorius are pivotal in driving innovation and market growth through extensive R&D, strategic partnerships, and global distribution networks.

Market Drivers

Growing Prevalence of Blood Disorders and Transfusion Rates

The rise in blood-related diseases, such as leukemia, and the increasing need for blood transfusions underscore the importance of efficient blood storage solutions. For instance, with every unit of blood transfusion, there is a 1% chance of transfusion-associated problems, including transfusion-transmitted diseases. The increasing prevalence of leukemia, which affects approximately 437,000 people worldwide annually, is driving the need for efficient blood storage solutions. Cryopreservation bags, specifically designed for blood component storage, play a crucial role in this domain. These bags ensure that blood and its components remain viable over extended periods, facilitating timely and effective medical interventions. As the prevalence of blood disorders continues to grow, the demand for robust cryopreservation solutions is expected to rise, supporting the healthcare sector in managing these conditions effectively.

Demand for Advanced Therapeutic Medicinal Products (ATMPs)

Advanced Therapeutic Medicinal Products (ATMPs), including cell and gene therapies, represent a rapidly expanding field in modern medicine. In the realm of ATMPs, the market is expected to grow by 25% annually, with over 900 ATMPs currently in development, highlighting the critical demand for cryopreservation solutions to maintain cell viability. For example, the cost of cryopreservation for a single ATMP treatment can range from $1,000 to $5,000, depending on the complexity of the therapy. These therapies often require the manipulation and storage of cells, necessitating the use of cryopreservation bags to maintain cell viability throughout the process. As the adoption of ATMPs increases, so does the need for high-quality cryopreservation solutions that can ensure the safety and effectiveness of these innovative treatments. Cryopreservation bags are essential in preserving the therapeutic potential of ATMPs, driving their growing demand in the medical field.

Growth in Cord Blood Banking

Cord blood banking is becoming increasingly popular as a source of stem cells for future medical treatments. Cord blood banking has seen a significant uptick, with the number of stored cord blood units worldwide surpassing 800,000. Cryopreservation bags designed for cord blood storage play a vital role in ensuring the long-term viability of these stem cells. The ability to store cord blood effectively opens up new possibilities for treating various medical conditions, including genetic disorders and certain types of cancers. As awareness of the benefits of cord blood banking grows, the demand for specialized cryopreservation solutions is expected to increase, further boosting the market for cryopreservation bags and freezing bags.

Rising Disposable Income

In many parts of the world, increasing disposable income is enabling individuals to invest more in preventive healthcare measures, including biobanking services that utilize cryopreservation technologies. This economic trend is driving greater demand for cryopreservation bags, as more people seek to preserve biological samples for future medical use. The rising affordability of advanced medical technologies and services is thus supporting the expansion of the cryopreservation bags and freezing bags market, aligning with the broader trend of proactive health management.

Focus on Automation and Material Advancements for Enhanced Performance

Laboratories are increasingly turning to automation to improve efficiency and reduce human error, driving the development of cryopreservation bags and freezing bags that integrate seamlessly with automated handling systems. For instance, laboratories are now automating up to 70% of their sample handling processes, which has led to a 30% reduction in human error and a 20% increase in overall efficiency. The development of cryopreservation bags and freezing bags compatible with automated systems is a response to this trend, with some systems showing a 25% improvement in workflow consistency. As for material advancements, the latest cryopreservation bags feature a 50% increase in gas permeability, contributing to a 15% higher cell viability rate after thawing. These material advancements not only improve the functionality of cryopreservation solutions but also enhance their reliability and safety, supporting a wide range of applications in biomedical research and clinical practice.

Growing Demand for Personalized Medicine and Integration of Monitoring Technologies

The rise of personalized medicine is significantly impacting the cryopreservation bags and freezing bags market. The personalized medicine market is expected to grow by 10% annually, driving the demand for customized cryopreservation solutions. For instance, the integration of RFID tags has improved sample tracking accuracy by 99.9%, ensuring that each sample’s viability and traceability are maintained throughout the storage period. This level of precision is crucial as the number of personalized treatments requiring tailored storage solutions has increased by 40% in the last year alone. This demand for customization extends to integrated tracking systems, allowing for precise management of individual samples. As personalized medicine continues to grow, the need for specialized cryopreservation solutions that ensure the viability and traceability of each sample becomes more critical.

In addition to customization, the integration of advanced monitoring technologies, such as radiofrequency identification (RFID) tags, is becoming increasingly important. These technologies enable real-time tracking and monitoring of sample conditions during storage, providing vital data that helps maintain the quality and viability of biological materials. This capability is essential for ensuring that samples are stored under optimal conditions and can be reliably retrieved when needed.

Market Challenges Analysis

Overcoming Limited Shelf Life and High Costs of Cryopreservation Technologies

One of the primary challenges in the Cryopreservation Bags and Freezing Bags market is the limited shelf life of samples. Despite significant advancements in cryopreservation techniques, ensuring indefinite viability of cells or tissues remains a hurdle. Continuous research is essential to enhance the long-term storage capabilities of cryopreservation bags, striving to maintain sample integrity over extended periods. This ongoing challenge underscores the need for innovation in both materials and methodologies to improve the durability and reliability of preserved samples. Additionally, the high cost of cryopreservation technologies presents a significant barrier. Cryopreservation bags and freezing bags, along with the necessary specialized equipment and trained personnel, contribute to substantial expenses for laboratories and biobanks. These costs can be prohibitive, particularly for smaller institutions or those in regions with limited resources. The financial burden extends beyond the purchase of cryopreservation bags to include maintenance of sophisticated storage systems and ensuring compliance with stringent standards. Addressing these cost challenges requires a focus on developing more cost-effective solutions and providing support for institutions to access advanced cryopreservation technologies.

Navigating Regulatory Requirements and Standardization Issues

Stringent regulatory requirements add another layer of complexity to the Cryopreservation Bags and Freezing Bags market. Regulatory bodies impose rigorous guidelines for the manufacturing, testing, and usage of these bags to ensure safety and efficacy. Compliance with these regulations can be intricate and expensive, demanding significant investments in research, development, and quality assurance from manufacturers. Navigating this regulatory landscape is crucial for maintaining market credibility and ensuring that products meet high standards. Moreover, standardization issues pose a significant challenge. While efforts towards creating universal standards are ongoing, the lack of consistent regulations across different regions and applications can hinder seamless integration of cryopreservation solutions. Compatibility challenges arise, complicating workflows and potentially affecting the efficiency of sample preservation. Addressing this requires a concerted effort towards harmonizing standards, which would facilitate smoother adoption and operation across various settings.

Market Segmentation Analysis:

By Type of Analyte Stored:

The Cryopreservation Bags and Freezing Bags market is segmented by the type of analyte stored, including blood, biologics, and tissues, each with unique preservation requirements. Blood storage is crucial due to the rising prevalence of blood disorders and the need for efficient transfusion solutions, necessitating cryopreservation bags that ensure cell viability over long periods. The biologics segment, encompassing vaccines, cell and gene therapies, and ATMPs, demands highly controlled environments to maintain stability and efficacy, driven by advancements in biotechnology and personalized medicine. Tissue storage, vital for research, transplantation, and regenerative medicine, requires robust cryopreservation solutions to protect against contamination and degradation, supporting the growth of tissue engineering and regenerative medicine. This segmentation underscores the diverse applications and specialized needs within the market, fostering innovation and expansion across biomedical research and clinical practices.

Segments:

Based on Type of Analyte Stored

  • Blood
  • Biologics
  • Tissues

Based on the Geography:

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Regional Analysis

North America

North America currently holds the largest market share in the cryopreservation bags and freezing bags market, accounting for approximately 35% of the global revenue. The region's well-established healthcare infrastructure, robust biopharmaceutical industry, and significant investments in stem cell research and regenerative medicine have fueled the demand for these specialized storage solutions. The United States, in particular, has been at the forefront of advancements in cell and tissue preservation techniques, contributing to the market's growth.

Europe

Europe follows closely with a market share of around 30%. Countries like Germany, France, and the United Kingdom have made substantial strides in the fields of cell and gene therapy, driving the need for reliable cryopreservation bags and freezing bags. The region's emphasis on medical research and the presence of leading pharmaceutical and biotechnology companies have further propelled the market's expansion.

Key Player Analysis

  • American Durafilm
  • Biomed Device
  • CellBios
  • Charter Medical
  • Instant Systems
  • Macopharma
  • OriGen Biomedical
  • Sartorius

Competitive Analysis

The competitive landscape of the Cryopreservation Bags and Freezing Bags market is shaped by key players such as American Durafilm, Biomed Device, CellBios, Charter Medical, Instant Systems, Macopharma, OriGen Biomedical, and Sartorius. These companies leverage extensive R&D capabilities to innovate and develop advanced cryopreservation solutions that meet stringent regulatory standards and the diverse needs of biomedical research and clinical applications. American Durafilm and Biomed Device focus on high-performance materials and custom solutions, enhancing product durability and reliability. CellBios and Charter Medical excel in providing cost-effective, scalable solutions for biobanking and therapeutic applications. Instant Systems and Macopharma emphasize safety and user-friendly designs, while OriGen Biomedical and Sartorius lead in integrating cutting-edge technologies such as RFID tracking and automation compatibility. Strategic partnerships, global distribution networks, and continuous innovation are critical strategies employed by these players to maintain their competitive edge and cater to the growing demand for effective cryopreservation solutions.

Recent Developments

  • In June 2023, SCTbio collaborated with Cyto-carein in order to improve the quality of cryopreservation for cell therapy development in Europe.
  • In February 2022, OriGen received CE mark approval for the CryoStore™ FLEX Freezing Bag product line. Additionally, the company announced the global launch of CryoStore™ FLEX freezing bag.

Market Concentration & Characteristics

The Cryopreservation Bags and Freezing Bags market exhibits moderate to high market concentration, with a few dominant players like Sartorius, OriGen Biomedical, and Macopharma leading the industry. These companies leverage robust R&D capabilities, advanced technological integration, and extensive global distribution networks to maintain their competitive edge. The market is characterized by high entry barriers due to stringent regulatory requirements, significant initial investment costs, and the need for specialized knowledge and technology. Innovation is a key characteristic, with ongoing advancements in biocompatible materials, enhanced leakproof features, and integration of monitoring technologies such as RFID. The market is also marked by a strong focus on quality and compliance, ensuring that products meet the rigorous standards necessary for preserving the integrity and viability of biological samples. This environment fosters continuous improvement and collaboration among key players to address the evolving needs of biomedical research and clinical application.

Report Coverage

The research report offers an in-depth analysis based on Type of Analyte Stored and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. Advancements in biocompatible materials will enhance the safety and efficacy of cryopreservation bags.
  2. Increased demand for biobanking and regenerative medicine will drive market growth.
  3. Integration of RFID and other tracking technologies will improve sample management and monitoring.
  4. Expansion in emerging markets, particularly in Asia-Pacific, will offer new growth opportunities.
  5. Development of cost-effective cryopreservation solutions will make these technologies more accessible.
  6. Growing prevalence of chronic diseases will boost the need for effective storage solutions for biological samples.
  7. Enhanced focus on personalized medicine will necessitate tailored cryopreservation solutions.
  8. Continued innovation in freezing techniques will improve long-term viability of stored samples.
  9. Regulatory advancements will streamline approval processes and ensure higher standards.
  10. Strategic partnerships and collaborations will foster innovation and expand market reach.
Cryopreservation Bags and Freezing Bags Market Size & Growth
Report Attribute Details
Details
Historical Period
-
Base Year
2024
Forecast Period
2024–2032
Cryopreservation Bags and Freezing Bags Size 2024
USD 921 million
Cryopreservation Bags and Freezing Bags CAGR
8.13%
Cryopreservation Bags and Freezing Bags Size 2032
USD 1,745.9 million

Request a Free Sample

Fill in your details and we'll send you a free sample report.

  • Sample data tables & charts
  • Research methodology

Market Dynamics

Growing Prevalence of Blood Disorders and Transfusion Rates

The increasing incidence of blood-related diseases such as leukemia and the rising need for blood transfusions are driving demand for efficient blood storage solutions. Cryopreservation bags are essential for maintaining the viability of blood components over extended periods, supporting timely and effective medical interventions.

Demand for Advanced Therapeutic Medicinal Products (ATMPs)

The rapid expansion of cell and gene therapies, which require the manipulation and storage of living cells, is fueling the need for high-quality cryopreservation bags. These bags are critical for preserving cell viability and therapeutic potential throughout the development and delivery of ATMPs.

Growth in Cord Blood Banking

The rising popularity of cord blood banking as a source of stem cells for future treatments is increasing the demand for specialized cryopreservation bags. These bags ensure the long-term viability of stored stem cells, enabling new possibilities for treating genetic disorders and cancers.

Rising Disposable Income

Higher disposable incomes in many regions are enabling more individuals to invest in preventive healthcare measures such as biobanking, which relies on cryopreservation technologies. This trend is expanding the customer base for cryopreservation bags and freezing bags.

Focus on Automation and Material Advancements

Laboratories are adopting automation and advanced materials to improve efficiency, reduce contamination risk, and enhance sample viability. Innovations such as automation-compatible bags and improved gas permeability are making cryopreservation solutions more reliable and effective, further driving market adoption.

Need a Custom Version of This Report?

Tailor the scope, geography, or segments to your exact requirements.

  • Custom geography or segment scope
  • Direct access to our analyst team

Frequently Asked Questions

What is the current size of the Cryopreservation Bags and Freezing Bags Market?
The Cryopreservation Bags and Freezing Bags market is projected to grow from USD 921 million in 2024 to USD 1,745.9 million by 2032, reflecting a compound annual growth rate (CAGR) of 8.13%.
What factors are driving the growth of the Cryopreservation Bags and Freezing Bags Market?
The growth of the Cryopreservation Bags and Freezing Bags market is driven by increasing demand for biobanking and regenerative medicine, advances in biotechnology, the growing focus on personalized medicine, the rise in chronic diseases, and the expansion of stem cell research.
What are the key segments within the Cryopreservation Bags and Freezing Bags Market?
Key segments within the Cryopreservation Bags and Freezing Bags market include the type of analyte stored, such as blood, biologics, and tissues, as well as geographic regions like North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.
What are some challenges faced by the Cryopreservation Bags and Freezing Bags Market?
Challenges faced by the Cryopreservation Bags and Freezing Bags market include the limited shelf life of samples, high costs of cryopreservation technologies, stringent regulatory requirements, standardization issues, and the need for improved user education.
Who are the major players in the Cryopreservation Bags and Freezing Bags Market?
Major players in the Cryopreservation Bags and Freezing Bags market include American Durafilm, Biomed Device, CellBios, Charter Medical, Instant Systems, Macopharma, OriGen Biomedical, and Sartorius.
Which segment is leading the market share?
The blood storage segment is leading the market share within the Cryopreservation Bags and Freezing Bags market, driven by the rising prevalence of blood disorders and the need for efficient transfusion solutions.

Table of Content

Chapter 1 Market Segmentation

  • 1.1 Segmentation Framework
    • 1.1.1 Product and Service Classification
    • 1.1.2 Application and End-Use Classification
    • 1.1.3 Technology and Solution Classification
    • 1.1.4 Customer and Distribution Channel Classification
    • 1.1.5 Geographic Segmentation
    • 1.1.6 Market Segment Definitions and Boundaries
  • 1.2 By End User
    • 1.2.1 Biobanks
    • 1.2.2 Hospitals & Transfusion Centers
    • 1.2.3 Research & Academic Institutes
    • 1.2.4 Pharmaceutical & Biotechnology Companies
  • 1.3 By Material
    • 1.3.1 EVA (Ethylene Vinyl Acetate)
    • 1.3.2 PVC (Polyvinyl Chloride)
    • 1.3.3 Polyolefin
    • 1.3.4 Others
  • 1.4 By Type of Analyte Stored
    • 1.4.1 Blood
    • 1.4.2 Biologics
    • 1.4.3 Tissues

Chapter 2 Introduction

  • 2.1 Report Objectives and Scope
  • 2.2 Product Definition and Industry Terminology
  • 2.3 Market Inclusions and Exclusions
  • 2.4 Research Process
    • 2.4.1 Primary Research and Expert Interviews
    • 2.4.2 Secondary Research and Source Review
    • 2.4.3 Top-Down and Bottom-Up Estimation
    • 2.4.4 Data Triangulation and Verification
  • 2.5 Market Size Measurement Basis
    • 2.5.1 2024: USD 921 million → 2032: USD 1,745.9 million
  • 2.6 Historical and Forecast Reference Periods
    • 2.6.1 Base Year: 2024
    • 2.6.2 Forecast Period: 2024-2032
  • 2.7 Research Assumptions and Limitations

Chapter 3 Executive Summary

  • 3.1 Market Snapshot and Key Findings
  • 3.2 Base-Year Market Size, 2024
  • 3.3 Forecast Market Size, 2032
  • 3.4 Revenue and Volume Growth Outlook
  • 3.5 Key Demand and Supply Indicators
  • 3.6 Leading Market Segments
  • 3.7 Fastest-Growing Market Opportunities
  • 3.8 Regional Performance Highlights
  • 3.9 Technology and Industry Transformation
  • 3.10 Competitive Landscape Summary
  • 3.11 Analyst View and Strategic Implications

Chapter 4 Global Cryopreservation Bags and Freezing Bags Market Trends and Developments

  • 4.1 Historical Industry Development
  • 4.2 Recent Market Trends and Developments
  • 4.3 Demand and Customer Behavior Trends
  • 4.4 Technology and Product Innovation
  • 4.5 Artificial Intelligence, Automation and Digitalization
  • 4.6 Local Manufacturing and Supply Chain Realignment
  • 4.7 Industry Partnerships, Mergers and Acquisitions
  • 4.8 Sustainability and Circular Economy Developments
  • 4.9 Government and Private Sector Investment Trends
  • 4.10 Emerging Business Models and Commercialization
  • 4.11 Industry Developments and Announcements

Chapter 5 Global Cryopreservation Bags and Freezing Bags Market Production, Supply and Demand Analysis

  • 5.1 Demand Trend and Consumption Analysis
  • 5.2 Demand Forecast, 2024-2032
  • 5.3 Production and Output Trend
  • 5.4 Production and Output Forecast, 2024-2032
  • 5.5 Installed Capacity and Capacity Utilization
  • 5.6 Company-Wise Production Plants and Statistics
    • 5.6.1 Installed Production Capacity
    • 5.6.2 Actual Production
    • 5.6.3 Planned Capacity and Expansion Targets
  • 5.7 Supply Chain Structure and Procurement Trends
  • 5.8 Supply-Demand Gap and Bottlenecks
  • 5.9 Import Dependence and Sourcing Structure
  • 5.10 Contract Manufacturing and Outsourcing
  • 5.11 Regional Supply and Demand Concentration

Chapter 6 Global Cryopreservation Bags and Freezing Bags Market Pricing Analysis

  • 6.1 Pricing Structure and Measurement
  • 6.2 Historical Pricing Trends
  • 6.3 Pricing Outlook, 2024-2032
  • 6.4 Average Selling Price and Unit Economics
  • 6.5 Pricing by Product and Market Segment
  • 6.6 Geographic Pricing Differences
  • 6.7 Key Input, Energy, Labor and Logistics Costs
  • 6.8 Contract Pricing and Purchasing Models
  • 6.9 Pricing Sensitivity and Competitive Positioning
  • 6.10 Price, Margin and Profitability Implications

Chapter 7 Global Cryopreservation Bags and Freezing Bags Market Dynamics

  • 7.1 Market Growth Drivers
    • 7.1.1 Demand-Side Drivers
    • 7.1.2 Technology and Innovation Drivers
    • 7.1.3 Infrastructure and Investment Drivers
    • 7.1.4 Regulatory and Policy Drivers
  • 7.2 Market Restraints
    • 7.2.1 Cost and Affordability Constraints
    • 7.2.2 Technology and Adoption Barriers
    • 7.2.3 Supply Chain and Operational Constraints
  • 7.3 Market Challenges
    • 7.3.1 Competitive Pressure and Margin Erosion
    • 7.3.2 Skills, Infrastructure and Implementation Gaps
  • 7.4 Emerging Market Opportunities
  • 7.5 Market Dynamics Impact and Time-Horizon Assessment

Chapter 8 Global Cryopreservation Bags and Freezing Bags Value Chain Analysis

  • 8.1 Industry Value Chain Overview
  • 8.2 Upstream Suppliers and Critical Inputs
  • 8.3 Technology and Component Providers
  • 8.4 Manufacturing or Service Delivery
  • 8.5 Distribution, Channel Partners and Integrators
  • 8.6 Downstream Applications and End Users
  • 8.7 Value Addition and Profit Pools
  • 8.8 Vertical Integration and Outsourcing
  • 8.9 Supplier Concentration and Risk
  • 8.10 Supply Chain Localization and Resilience

Chapter 9 Global Cryopreservation Bags and Freezing Bags Market Regulations and Policies

  • 9.1 Relevant Laws, Standards and Compliance Frameworks
  • 9.2 Product, Service, Safety and Quality Requirements
  • 9.3 Government Policies, Incentives and Subsidies
  • 9.4 Imports, Exports and Trade Barriers
  • 9.5 Public Procurement and Local Content Requirements
  • 9.6 Environmental and Sustainability Compliance
  • 9.7 Upcoming Policy Changes and Market Implications

Chapter 10 Global Cryopreservation Bags and Freezing Bags Market Hotspots and Opportunities

  • 10.1 Market Opportunity Mapping and Growth Hotspots
  • 10.2 High-Growth Applications and Customer Groups
  • 10.3 Underserved Markets and White-Space Opportunities
  • 10.4 Emerging Technology and Product Opportunities
  • 10.5 New Capacity and Investment Hotspots
  • 10.6 Market Entry and Expansion Opportunities
  • 10.7 Distribution and Partnership Opportunities
  • 10.8 Near-Term and Long-Term Commercial Potential
  • 10.9 Opportunity Attractiveness and Execution Risks

Chapter 11 Global Cryopreservation Bags and Freezing Bags Market Outlook, 2024-2032

  • 11.1 Market Size and Analysis
    • 11.1.1 Revenue (Market Measurement: 2024: USD 921 million → 2032: USD 1,745.9 million)
    • 11.1.2 Market Volume and Quantity Sold
    • 11.1.3 Historical Market Size
    • 11.1.4 Base-Year Market Size, 2024
  • 11.2 Market Forecast, 2024-2032
    • 11.2.1 Revenue Forecast to 2032
    • 11.2.2 Volume Forecast to 2032
    • 11.2.3 CAGR and Year-on-Year Growth
    • 11.2.4 Incremental Revenue Opportunity
  • 11.3 Forecast Assumptions and Scenario Analysis
    • 11.3.1 Base-Case Forecast
    • 11.3.2 Optimistic and Conservative Scenarios
    • 11.3.3 Technology, Pricing and Policy Sensitivities
  • 11.4 Market Attractiveness and Growth Outlook

Chapter 12 Global Cryopreservation Bags and Freezing Bags Market Segmentation and Outlook

  • 12.1 Segmentation Summary and Market Shares, 2024
  • 12.2 Largest and Fastest-Growing Segments
  • 12.3 By End User - Market Size and Forecast, 2024-2032
    • 12.3.1 Segment Definition and Scope
    • 12.3.2 Historical Market Size
    • 12.3.3 Revenue Forecast, 2024-2032
    • 12.3.4 Volume Forecast, 2024-2032
    • 12.3.5 Base-Year Market Share, 2024
    • 12.3.6 Segment CAGR and Growth Drivers
    • 12.3.7 Subsegment Market Size and Forecast
      • 12.3.7.1 Biobanks
      • 12.3.7.2 Hospitals & Transfusion Centers
      • 12.3.7.3 Research & Academic Institutes
      • 12.3.7.4 Pharmaceutical & Biotechnology Companies
    • 12.3.8 Subsegment Pricing and Adoption Trends
    • 12.3.9 Leading Suppliers and Competition
    • 12.3.10 Regional Demand and Opportunities
  • 12.4 By Material - Market Size and Forecast, 2024-2032
    • 12.4.1 Segment Definition and Scope
    • 12.4.2 Historical Market Size
    • 12.4.3 Revenue Forecast, 2024-2032
    • 12.4.4 Volume Forecast, 2024-2032
    • 12.4.5 Base-Year Market Share, 2024
    • 12.4.6 Segment CAGR and Growth Drivers
    • 12.4.7 Subsegment Market Size and Forecast
      • 12.4.7.1 EVA (Ethylene Vinyl Acetate)
      • 12.4.7.2 PVC (Polyvinyl Chloride)
      • 12.4.7.3 Polyolefin
      • 12.4.7.4 Others
    • 12.4.8 Subsegment Pricing and Adoption Trends
    • 12.4.9 Leading Suppliers and Competition
    • 12.4.10 Regional Demand and Opportunities
  • 12.5 By Type of Analyte Stored - Market Size and Forecast, 2024-2032
    • 12.5.1 Segment Definition and Scope
    • 12.5.2 Historical Market Size
    • 12.5.3 Revenue Forecast, 2024-2032
    • 12.5.4 Volume Forecast, 2024-2032
    • 12.5.5 Base-Year Market Share, 2024
    • 12.5.6 Segment CAGR and Growth Drivers
    • 12.5.7 Subsegment Market Size and Forecast
      • 12.5.7.1 Blood
      • 12.5.7.2 Biologics
      • 12.5.7.3 Tissues
    • 12.5.8 Subsegment Pricing and Adoption Trends
    • 12.5.9 Leading Suppliers and Competition
    • 12.5.10 Regional Demand and Opportunities
  • 12.6 Segment Growth Comparison
  • 12.7 Segment Attractiveness and Priority Matrix

Chapter 13 Global Cryopreservation Bags and Freezing Bags End-Use and Application Market Outlook

  • 13.1 End-Use Industry and Customer Demand Structure
  • 13.2 Leading Applications and Customer Groups
  • 13.3 End-Use Market Size, Share and Forecast
  • 13.4 Major End-Use Industry Deep Dives
    • 13.4.1 Customer Requirements and Use Cases
    • 13.4.2 Demand and Replacement Cycles
    • 13.4.3 Technical and Regulatory Considerations
    • 13.4.4 Purchasing and Procurement Models
    • 13.4.5 Leading Vendors and Distribution Channels
    • 13.4.6 Forecast and Commercial Opportunities
  • 13.5 Emerging Applications and Cross-Segment Demand
  • 13.6 End-Use Industry Investment Priorities

Chapter 14 Global Cryopreservation Bags and Freezing Bags Geographic Market Outlook, 2024-2032

  • 14.1 Regional Market Size and Share, 2024
  • 14.2 Regional Market Forecast, 2024-2032
  • 14.3 Regional Pricing, Production and Demand Differences
  • 14.4 North America
    • 14.4.1 United States
    • 14.4.2 Canada
    • 14.4.3 Mexico
  • 14.5 Europe
    • 14.5.1 Germany
    • 14.5.2 France
    • 14.5.3 Italy
    • 14.5.4 United Kingdom
    • 14.5.5 Spain
    • 14.5.6 Poland
    • 14.5.7 Russia
    • 14.5.8 Netherlands
    • 14.5.9 Belgium
    • 14.5.10 Sweden
    • 14.5.11 Denmark
    • 14.5.12 Norway
    • 14.5.13 Rest of Europe
  • 14.6 Asia Pacific
    • 14.6.1 China
    • 14.6.2 India
    • 14.6.3 Japan
    • 14.6.4 South Korea
    • 14.6.5 Thailand
    • 14.6.6 Indonesia
    • 14.6.7 Vietnam
    • 14.6.8 Malaysia
    • 14.6.9 Australia
    • 14.6.10 Rest of Asia Pacific
  • 14.7 Latin America
    • 14.7.1 Brazil
    • 14.7.2 Argentina
    • 14.7.3 Colombia
    • 14.7.4 Chile
    • 14.7.5 Rest of Latin America
  • 14.8 Middle East
    • 14.8.1 Saudi Arabia
    • 14.8.2 United Arab Emirates
    • 14.8.3 Turkey
    • 14.8.4 Israel
    • 14.8.5 Iran
    • 14.8.6 Rest of the Middle East
  • 14.9 Africa
    • 14.9.1 South Africa
    • 14.9.2 Egypt
    • 14.9.3 Nigeria
    • 14.9.4 Morocco
    • 14.9.5 Rest of Africa
  • 14.10 Regional Investment, Policy and Supply Chain Differences
  • 14.11 Regional Competitive Landscape
  • 14.12 Geographic Growth Hotspots

Chapter 15 Global Cryopreservation Bags and Freezing Bags Technology, Innovation and Sustainability Outlook

  • 15.1 Technology Landscape and Maturity
  • 15.2 Product, Process and Service Innovation
  • 15.3 AI, Automation and Digital Tools in the Industry
  • 15.4 Technology Adoption and Performance Benchmarking
  • 15.5 Innovation Pipeline and R&D Investment
  • 15.6 Patent and Intellectual Property Trends
  • 15.7 Energy Efficiency and Resource Management
  • 15.8 Sustainability, Recycling and Circularity
  • 15.9 Technology Roadmap, 2024-2032
  • 15.10 Risks of Obsolescence and Technology Substitution

Chapter 16 Global Cryopreservation Bags and Freezing Bags Market Key Strategic Imperatives

  • 16.1 Growth and Market Entry Priorities
  • 16.2 High-Return Products and Segments
  • 16.3 Pricing, Profitability and Cost Optimization
  • 16.4 Technology Investment and Product Differentiation
  • 16.5 Supply Chain Localization and Resilience
  • 16.6 Distribution and Customer Acquisition
  • 16.7 Partnership, Acquisition and Capacity Strategy
  • 16.8 Regional Expansion Priorities
  • 16.9 Short-, Medium- and Long-Term Actions

Chapter 17 Competition Outlook

  • 17.1 Industry Competition Characteristics
  • 17.2 Market Structure and Concentration
  • 17.3 Market Share and Competitive Positioning, 2024
  • 17.4 Company-Wise Revenue and Product Benchmarking
  • 17.5 Production and Service Capacity Benchmarking
  • 17.6 Technology, Pricing and Differentiation
  • 17.7 Regional Footprint and Distribution Strength
  • 17.8 Mergers, Acquisitions and Strategic Alliances
  • 17.9 New Entrants and Competitive Threats
  • 17.10 Porter's Five Forces and Industry Attractiveness
  • 17.11 Competitive Outlook, 2024-2032

Chapter 18 Company Profiles

  • 18.1 Company Coverage and Selection Criteria
  • 18.2 Sartorius
    • 18.2.1 Business Description
    • 18.2.2 Company Ownership and Geographic Presence
    • 18.2.3 Product and Service Portfolio
    • 18.2.4 Manufacturing and Operating Footprint
    • 18.2.5 Production Capacity and Expansion Plans
    • 18.2.6 Financial Performance and Investment
    • 18.2.7 Market Share and Competitive Position
    • 18.2.8 Technology and Innovation Capabilities
    • 18.2.9 Strategic Alliances or Partnerships
    • 18.2.10 Recent Developments
    • 18.2.11 Growth Strategy and Outlook
  • 18.3 OriGen Biomedical
  • 18.4 Macopharma
  • 18.5 Charter Medical
  • 18.6 CellBios
  • 18.7 American Durafilm
  • 18.8 Biomed Device
  • 18.9 Instant Systems
  • 18.10 Terumo BCT
  • 18.11 Fresenius Kabi
  • 18.12 Other Relevant Market Participants

Note: Every listed company is profiled on the structure shown under the first company. The company list is preliminary and may change based on research findings, market developments, data availability and client requirements.

Chapter 19 Disclaimer

  • 19.1 Research and Forecast Disclaimer
  • 19.2 Data Source and Estimation Limitations

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.

Methodology

Meet the Team

Rajdeep Kumar Deb
Rajdeep Kumar Deb

Lead Analyst - Consumer & Finance

Rajdeep brings a decade of consumer goods and financial services insight to strategic market analysis.

Deepti Agrawal

Reviewed by

Deepti Agrawal

Head of Editorial Operations

Related Topics

Brazil Digital Health Wearables Market Size, Share, Growth and Forecast, 2025-2035

Brazil digital health wearables market worth USD 1.49 billion in 2025 is forecast to reach USD 4.91 billion by 2035, rising at a 12.61% CAGR on chronic care

USA Female External Catheters Market Size, Share, Growth and Forecast, 2025-2035

USA female external catheters market worth USD 214.5 million in 2025 is set to reach USD 588.4 million by 2035 at a 10.17% CAGR as hospitals cut Foley use.

Egypt Radiology Equipment Market Size, Share, Growth and Forecast, 2025-2035

Egypt radiology equipment market worth USD 209.5 million in 2025 will reach USD 395.8 million by 2035 at a 6.27% CAGR as insurance and cancer care expand.

United States Animal Wound Care Market Size, Share, Growth and Forecast, 2025-2035

United States animal wound care market worth USD 294.5 million in 2025 is forecast to reach USD 519.2 million by 2035, rising at a 5.83% CAGR on insured care

U.S. Pen Needles Market Size, Share, Growth and Forecast, 2025-2035

U.S. pen needles market worth USD 913.5 million in 2025 is forecast to reach USD 2.23 billion by 2035, rising at a 9.32% CAGR on insulin refills and GLP-1 pens

USA Angioplasty Balloons Market Size, Share, Growth and Forecast, 2025-2035

USA angioplasty balloons market worth USD 936.5 million in 2025 reaches USD 1.30 billion by 2035 at a 3.24% CAGR as coronary drug-coated balloons spread.